BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8993982)

  • 1. Complexity of 12q13-22 amplicon in liposarcoma: microsatellite repeat analysis.
    Wolf M; Aaltonen LA; Szymanska J; Tarkkanen M; Blomqvist C; Berner JM; Myklebost O; Knuutila S
    Genes Chromosomes Cancer; 1997 Jan; 18(1):66-70. PubMed ID: 8993982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsatellite markers as tools for characterization of DNA amplifications evaluated by comparative genomic hybridization.
    Wolf M; Aaltonen LA; Szymanska J; Tarkkanen M; Elomaa I; Knuutila S
    Cancer Genet Cytogenet; 1997 Jan; 93(1):33-8. PubMed ID: 9062578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of the 12q13-15 amplicon in soft tissue tumors.
    Nilbert M; Rydholm A; Mitelman F; Meltzer PS; Mandahl N
    Cancer Genet Cytogenet; 1995 Aug; 83(1):32-6. PubMed ID: 7656201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon.
    Italiano A; Bianchini L; Keslair F; Bonnafous S; Cardot-Leccia N; Coindre JM; Dumollard JM; Hofman P; Leroux A; Mainguené C; Peyrottes I; Ranchere-Vince D; Terrier P; Tran A; Gual P; Pedeutour F
    Int J Cancer; 2008 May; 122(10):2233-41. PubMed ID: 18214854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the 17p amplicon in human sarcomas: microsatellite marker analysis.
    Wolf M; Tarkkanen M; Hulsebos T; Larramendy ML; Forus A; Myklebost O; Aaltonen LA; Elomaa I; Knuutila S
    Int J Cancer; 1999 Jul; 82(3):329-33. PubMed ID: 10399948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-resolution genomic mapping reveals consistent amplification of the fibroblast growth factor receptor substrate 2 gene in well-differentiated and dedifferentiated liposarcoma.
    Wang X; Asmann YW; Erickson-Johnson MR; Oliveira JL; Zhang H; Moura RD; Lazar AJ; Lev D; Bill K; Lloyd RV; Yaszemski MJ; Maran A; Oliveira AM
    Genes Chromosomes Cancer; 2011 Nov; 50(11):849-58. PubMed ID: 21793095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular abnormalities in liposarcoma: role of MDM2 and CDK4-containing amplicons at 12q13-22.
    Pilotti S; Della Torre G; Lavarino C; Sozzi G; Minoletti F; Vergani B; Azzarelli A; Rilke F; Pierotti MA
    J Pathol; 1998 Jun; 185(2):188-90. PubMed ID: 9713346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of the 12q amplicons in lipomatous soft tissue tumors by multiplex ligation-dependent probe amplification-based copy number analysis.
    Creytens D; Van Gorp J; Speel EJ; Ferdinande L
    Anticancer Res; 2015 Apr; 35(4):1835-42. PubMed ID: 25862836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative genomic hybridization as a tool to define two distinct chromosome 12-derived amplification units in well-differentiated liposarcomas.
    Suijkerbuijk RF; Olde Weghuis DE; Van den Berg M; Pedeutour F; Forus A; Myklebost O; Glier C; Turc-Carel C; Geurts van Kessel A
    Genes Chromosomes Cancer; 1994 Apr; 9(4):292-5. PubMed ID: 7519052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas.
    Berner JM; Forus A; Elkahloun A; Meltzer PS; Fodstad O; Myklebost O
    Genes Chromosomes Cancer; 1996 Dec; 17(4):254-9. PubMed ID: 8946207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A different view on DNA amplifications indicates frequent, highly complex, and stable amplicons on 12q13-21 in glioma.
    Fischer U; Keller A; Leidinger P; Deutscher S; Heisel S; Urbschat S; Lenhof HP; Meese E
    Mol Cancer Res; 2008 Apr; 6(4):576-84. PubMed ID: 18403636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coordinated expression and amplification of the MDM2, CDK4, and HMGI-C genes in atypical lipomatous tumours.
    Dei Tos AP; Doglioni C; Piccinin S; Sciot R; Furlanetto A; Boiocchi M; Dal Cin P; Maestro R; Fletcher CD; Tallini G
    J Pathol; 2000 Apr; 190(5):531-6. PubMed ID: 10727978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets.
    Reifenberger G; Ichimura K; Reifenberger J; Elkahloun AG; Meltzer PS; Collins VP
    Cancer Res; 1996 Nov; 56(22):5141-5. PubMed ID: 8912848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A newly characterized human well-differentiated liposarcoma cell line contains amplifications of the 12q12-21 and 10p11-14 regions.
    Pedeutour F; Maire G; Pierron A; Thomas DM; Garsed DW; Bianchini L; Duranton-Tanneur V; Cortes-Maurel A; Italiano A; Squire JA; Coindre JM
    Virchows Arch; 2012 Jul; 461(1):67-78. PubMed ID: 22678079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the 12q15 MDM2 and 12q13-14 CDK4 amplicons and clinical correlations in osteosarcoma.
    Mejia-Guerrero S; Quejada M; Gokgoz N; Gill M; Parkes RK; Wunder JS; Andrulis IL
    Genes Chromosomes Cancer; 2010 Jun; 49(6):518-25. PubMed ID: 20196171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2.
    Reifenberger G; Reifenberger J; Ichimura K; Meltzer PS; Collins VP
    Cancer Res; 1994 Aug; 54(16):4299-303. PubMed ID: 8044775
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CDK4 is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer.
    Wikman H; Nymark P; Väyrynen A; Jarmalaite S; Kallioniemi A; Salmenkivi K; Vainio-Siukola K; Husgafvel-Pursiainen K; Knuutila S; Wolf M; Anttila S
    Genes Chromosomes Cancer; 2005 Feb; 42(2):193-9. PubMed ID: 15543620
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the 12q amplicons by high-resolution, oligonucleotide array CGH and expression analyses of a novel liposarcoma cell line.
    Persson F; Olofsson A; Sjögren H; Chebbo N; Nilsson B; Stenman G; Aman P
    Cancer Lett; 2008 Feb; 260(1-2):37-47. PubMed ID: 18160213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complex composition and co-amplification of SAS and MDM2 in ring and giant rod marker chromosomes in well-differentiated liposarcoma.
    Pedeutour F; Suijkerbuijk RF; Forus A; Van Gaal J; Van de Klundert W; Coindre JM; Nicolo G; Collin F; Van Haelst U; Huffermann K
    Genes Chromosomes Cancer; 1994 Jun; 10(2):85-94. PubMed ID: 7520271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes: a comparative analysis of 559 soft tissue neoplasms with genetic data.
    Binh MB; Sastre-Garau X; Guillou L; de Pinieux G; Terrier P; Lagacé R; Aurias A; Hostein I; Coindre JM
    Am J Surg Pathol; 2005 Oct; 29(10):1340-7. PubMed ID: 16160477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.